Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2012 07:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces First Quarter 2012 Financial Results

CAMBRIDGE, Mass., May 1, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
April 30, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces FDA Acceptance of New Drug Application for Review

CAMBRIDGE, Mass., April 30, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
April 24, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Announce First Quarter 2012 Financial Results on Tuesday, May 1

CAMBRIDGE, Mass., April 24, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
March 28, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Present at the Needham Healthcare Conference

CAMBRIDGE, Mass., March 28, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
March 20, 2012 07:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces EMA Acceptance for Review of Marketing Authorization Application for Lomitapide

CAMBRIDGE, Mass., March 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
March 08, 2012 09:20 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Comments on Standard Review Classification for Lomitapide NDA

CAMBRIDGE, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
March 06, 2012 07:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results

CAMBRIDGE, Mass., March 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
March 05, 2012 07:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Submits Marketing Applications for Lomitapide in U.S. and EU

CAMBRIDGE, Mass., March 5, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
February 29, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Observes Rare Disease Day 2012

CAMBRIDGE, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
February 27, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2011 Financial Results on Tuesday, March 6

CAMBRIDGE, Mass., Feb. 27, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...